Business
Press Release Dec 03 2023
Granules India Limited has informed the Exchange regarding a press release dated December 03, 2023, titled "Granules India Limited Received ANDA Approval for Sildenafil for Oral Suspension.".
About this update from Granules India Limited
[{"type":"text","content":" Granules India Limited has informed the Exchange regarding a press release dated December 03, 2023, titled \"Granules India Limited Received ANDA Approval for Sildenafil for Oral Suspension.\". View Attachment","length":338,"tagName":"div"}]